137 related articles for article (PubMed ID: 22429374)
1. Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.
Alsagaff MY; Thaha M; Aminuddin M; Yogiarto RM; Yogiantoro M; Tomino Y
J Int Med Res; 2012; 40(1):340-9. PubMed ID: 22429374
[TBL] [Abstract][Full Text] [Related]
2. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients.
Kocak H; Gumuslu S; Ermis C; Mahsereci E; Sahin E; Gocmen AY; Ersoy F; Suleymanlar G; Yakupoglu G; Tuncer M
Am J Nephrol; 2008; 28(1):91-6. PubMed ID: 17914250
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Kielstein JT; Zoccali C
Am J Kidney Dis; 2005 Aug; 46(2):186-202. PubMed ID: 16112037
[TBL] [Abstract][Full Text] [Related]
5. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study.
Mels CMC; Schutte AE; Huisman HW; Smith W; Kruger R; van Rooyen JM; Schwedhelm E; Atzler D; Böger RH; Malan NT; Malan L
Amino Acids; 2017 Nov; 49(11):1843-1853. PubMed ID: 28831582
[TBL] [Abstract][Full Text] [Related]
7. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic.
Osorio-Yáñez C; Ayllon-Vergara JC; Aguilar-Madrid G; Arreola-Mendoza L; Hernández-Castellanos E; Barrera-Hernández A; De Vizcaya-Ruiz A; Del Razo LM
Environ Health Perspect; 2013 Sep; 121(9):1090-6. PubMed ID: 23757599
[TBL] [Abstract][Full Text] [Related]
8. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
[TBL] [Abstract][Full Text] [Related]
9. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
10. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918
[TBL] [Abstract][Full Text] [Related]
11. Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis.
Wang F; Xiong R; Feng S; Lu X; Li H; Wang S
Kidney Blood Press Res; 2018; 43(1):25-33. PubMed ID: 29393214
[TBL] [Abstract][Full Text] [Related]
12. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
[TBL] [Abstract][Full Text] [Related]
13. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
14. HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children.
Ayer JG; Harmer JA; Nakhla S; Xuan W; Ng MK; Raitakari OT; Marks GB; Celermajer DS
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):943-9. PubMed ID: 19359663
[TBL] [Abstract][Full Text] [Related]
15. Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography.
Furuki K; Adachi H; Enomoto M; Otsuka M; Fukami A; Kumagae S; Matsuoka H; Nanjo Y; Kakuma T; Imaizumi T
Hypertens Res; 2008 Jun; 31(6):1185-9. PubMed ID: 18716367
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
van Guldener C; Nanayakkara PW; Stehouwer CD
Clin Chem Lab Med; 2007; 45(12):1683-7. PubMed ID: 17937610
[TBL] [Abstract][Full Text] [Related]
17. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
Zoccali C; Bode-Böger S; Mallamaci F; Benedetto F; Tripepi G; Malatino L; Cataliotti A; Bellanuova I; Fermo I; Frölich J; Böger R
Lancet; 2001 Dec 22-29; 358(9299):2113-7. PubMed ID: 11784625
[TBL] [Abstract][Full Text] [Related]
19. Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis.
Riccioni G; Bucciarelli V; Scotti L; Aceto A; D Orazio N; Di Ilio E; Bucciarelli T
J Biol Regul Homeost Agents; 2010; 24(3):351-8. PubMed ID: 20846483
[TBL] [Abstract][Full Text] [Related]
20. ASYMMETRIC DIMETHYLARGININE LEVELS AND ATHEROSCLEROSIS MARKERS IN CUSHING SYNDROME.
Ozsurekci CG; Akturk M; Ozkan C; Gulbahar O; Altinova AE; Yalcin M; Arslan E; Toruner F
Endocr Pract; 2016 Sep; 22(9):1088-95. PubMed ID: 27359292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
